Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021
Cash flows from operating activities:
Net income	$ 80,803	$ 46,804
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization and write-off of deferred debt issuance costs	57	1,161
Impairment (gain) of assets	(398)	(2,103)
Depreciation and amortization	11,748	13,031
Deferred taxes, net of valuation allowance	(33,480)
Stock compensation expense	1,053	938
Board of directors stock compensation	375	296
Changes in operating assets and liabilities:
Accounts receivable	1,094	4,812
Inventories	(25,052)	2,744
Prepaid expenses and other current assets	(1,892)	(3,237)
Other assets	(61)	360
Accounts payable	1,399	2,674
Operating leases, net	(5,590)	(12,275)
Accrued expenses and other liabilities	113	8,945
Net cash provided by operating activities	30,169	64,150
Cash flows from investing activities:
Additions to property and equipment, net	(7,853)	(2,802)
Net cash used for investing activities	(7,853)	(2,802)
Cash flows from financing activities:
Repurchase of common stock	(12,728)
Proceeds from issuance of common stock from private direct offering, net of offering costs		4,375
Repayment of FILO loan		(32,500)
Proceeds from new FILO loan		17,500
Net repayments under credit facility		(59,733)
Debt extinguishment costs		(1,111)
Debt issuance costs		(1,143)
Tax withholdings paid related to net share settlements	(1,845)	(1,146)
Proceeds from the exercise of stock options	236	350
Net cash used for financing activities	(14,337)	(73,408)
Net increase (decrease) in cash and cash equivalents	7,979	(12,060)
Cash and cash equivalents:
Beginning of period	15,506	18,997
End of period	$ 23,485	$ 6,937